Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases.

Khanh PhamHeidi TorresMichael J SatlinParag GoyalRoy M Gulick

Published in: Rheumatology advances in practice (2021)

HCQ therapy in individuals with rheumatic conditions was not associated with less severe presentations of COVID-19 among hospitalized patients compared with individuals with rheumatic conditions not receiving HCQ.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
early onset
drug induced
stem cells
bone marrow
replacement therapy